Aarti Asnani Selected Research

Aarti Asnani Research Topics

Disease

21	Cardiotoxicity 04/2024 - 12/2014
18	Neoplasms (Cancer) 04/2024 - 12/2014
11	Cardiomyopathies (Cardiomyopathy) 04/2024 - 07/2014
9	Heart Failure 04/2024 - 11/2018
5	Myocarditis (Carditis) 05/2022 - 11/2018
5	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 07/2008
4	Cardiac Arrhythmias (Arrythmia) 05/2022 - 11/2018
3	Breast Neoplasms (Breast Cancer) 12/2022 - 01/2020
2	Atrial Fibrillation 04/2023 - 01/2017
2	COVID-19 11/2022 - 01/2021
2	Second Primary Neoplasms (Neoplasms, Second) 01/2021 - 01/2018
2	Myocardial Infarction 01/2018 - 07/2014
1	Inflammation (Inflammations) 04/2024
1	Atrophy 01/2023
1	Lymphoma (Lymphomas) 01/2023
1	Sickle Cell Anemia (Hemoglobin S Disease) 10/2022
1	Hemolysis 10/2022
1	Iron Overload 10/2022
1	Kidney Diseases (Kidney Disease) 01/2021
1	Sudden Death 01/2021
1	Acute Kidney Injury (Acute Renal Failure) 01/2021
1	Venous Thromboembolism 11/2020
1	Brain Diseases (Brain Disorder) 11/2020
1	Shock 11/2020
1	Leukemia 01/2020
1	Necrosis 01/2020
1	Coronary Vasospasm (Coronary Artery Vasospasm) 01/2020
1	Hypotension (Low Blood Pressure) 11/2018
1	Cardiogenic Shock 11/2018
1	Left Ventricular Dysfunction 11/2018
1	Cytokine Release Syndrome 11/2018
1	Myocardial Bridging 07/2018
1	Chest Pain (Chest Pains) 07/2018
1	Melanoma (Melanoma, Malignant) 01/2018
1	Lung Neoplasms (Lung Cancer) 01/2018
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2018
1	Hemorrhage 01/2017
1	Cicatrix (Scar) 07/2014
1	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 07/2014

Drug/Important Bio-Agent (IBA)

13	AnthracyclinesIBA 04/2024 - 01/2018
9	Doxorubicin (Adriamycin)FDA LinkGeneric 04/2024 - 12/2014
5	Biomarkers (Surrogate Marker)IBA 01/2021 - 08/2011
4	Immune Checkpoint InhibitorsIBA 05/2022 - 01/2018
3	Trastuzumab (Herceptin)FDA Link 12/2021 - 01/2020
3	Fluorouracil (Carac)FDA LinkGeneric 01/2021 - 07/2018
3	visnaginIBA 01/2020 - 12/2014
2	Proteins (Proteins, Gene)FDA Link 01/2023 - 08/2011
2	HemopexinIBA 12/2022 - 10/2022
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 12/2021 - 12/2021
2	Niacinamide (Nicotinamide)FDA LinkGeneric 01/2021 - 05/2010
2	uridine triacetateIBA 01/2021 - 06/2020
2	TroponinIBA 11/2020 - 01/2018
2	Antineoplastic Agents (Antineoplastics)IBA 01/2019 - 05/2018
2	malic acid (malate)IBA 12/2014 - 05/2010
1	Cytochrome P-450 CYP1A1 (CYP1A1)IBA 04/2024
1	ChemokinesIBA 04/2024
1	Cytochrome P450 Family 1IBA 04/2024
1	RNA (Ribonucleic Acid)IBA 04/2024
1	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 03/2023
1	Apolipoproteins MIBA 03/2023
1	ProlactinIBA 02/2023
1	Transcription Factors (Transcription Factor)IBA 01/2023
1	Atorvastatin (Lipitor)FDA Link 01/2023
1	Growth Differentiation Factor 15IBA 01/2023
1	Heme-Binding ProteinsIBA 12/2022
1	Ritonavir (Norvir)FDA Link 11/2022
1	Cardiovascular AgentsIBA 11/2022
1	erastinIBA 10/2022
1	Heme (Haem)IBA 10/2022
1	IronIBA 10/2022
1	Heme Oxygenase-1IBA 10/2022
1	AntidotesIBA 01/2021
1	Oxygen (Dioxygen)IBA 11/2020
1	Thymidylate SynthaseIBA 06/2020
1	Citric Acid (Citrate)FDA LinkGeneric 01/2020
1	NucleosidesIBA 01/2020
1	Capecitabine (Xeloda)FDA Link 01/2020
1	pyrimidineIBA 01/2020
1	Aconitic Acid (Aconitate)IBA 01/2020
1	purineIBA 01/2020
1	AntibodiesIBA 01/2020
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2019
1	Chimeric Antigen ReceptorsIBA 11/2018
1	Cytotoxins (Cytolysins)IBA 05/2018
1	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2018
1	AnticoagulantsIBA 01/2017
1	Anti-Arrhythmia AgentsIBA 01/2017
1	IodineIBA 12/2014
1	Mebendazole (Anti-Worm)FDA Link 12/2014
1	Malate Dehydrogenase (Dehydrogenase, Malate)IBA 12/2014
1	Thyroxine (Levothyroxine)FDA LinkGeneric 12/2014
1	ConnectinIBA 07/2014

Therapy/Procedure

11	Therapeutics 04/2023 - 07/2014
11	Drug Therapy (Chemotherapy) 01/2023 - 12/2014
1	Aftercare (After-Treatment) 11/2023
1	Catheter Ablation 04/2023
1	Heart Transplantation (Grafting, Heart) 05/2022
1	Artificial Respiration (Mechanical Ventilation) 11/2020
1	Length of Stay 11/2020
1	Immunotherapy 11/2018